Physician profile
Lawrence Ham
NPI 1235806621
$1,012.90
in general payments reported to CMS, 2019-2025
12 companies · $454 in 2025
The $454 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $559 · 2025: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,013.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,012.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $153.11 | 2024 | Biktarvy |
| Madrigal Pharmaceuticals | $124.99 | 2025 | Rezdiffra |
| Novo Nordisk INC | $113.86 | 2024 | |
| Si-Bone, INC. | $112.25 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $112.08 | 2025 | |
| Janssen Pharmaceuticals, INC | $109.29 | 2025 | Spravato |
| Astrazeneca Pharmaceuticals LP | $107.91 | 2025 | Fasenra |
| Biogen, INC. | $93.19 | 2024 | Spinraza |
| Merck Sharp & Dohme LLC | $25.06 | 2024 | Gardasil, Capvaxive, Gardasil 9 |
| Pfizer INC. | $21.55 | 2024 | |
| Phadia US INC. | $20.27 | 2024 | Immunocap |
| Organon LLC | $19.34 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Ham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.